【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Myasthenia Gravis Overview 8
Therapeutics Development 9
Pipeline Products for Myasthenia Gravis – Overview 9
Pipeline Products for Myasthenia Gravis – Comparative Analysis 10
Myasthenia Gravis – Therapeutics under Development by Companies 11
Myasthenia Gravis – Therapeutics under Investigation by Universities/Institutes 13
Myasthenia Gravis – Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Myasthenia Gravis – Products under Development by Companies 17
Myasthenia Gravis – Products under Investigation by Universities/Institutes 18
Myasthenia Gravis – Companies Involved in Therapeutics Development 19
Alexion Pharmaceuticals, Inc. 19
Alnylam Pharmaceuticals, Inc. 20
Astellas Pharma Inc. 21
Biokine Therapeutics Ltd. 22
CuraVac, Inc. 23
Cytokinetics, Inc. 24
GlaxoSmithKline plc 25
Grifols, S.A. 26
HanAll Biopharma Co., Ltd. 27
Neurotune AG 28
Pfizer Inc. 29
Regenesance BV 30
Toleranzia AB 31
Myasthenia Gravis – Therapeutics Assessment 32
Assessment by Monotherapy Products 32
Assessment by Target 33
Assessment by Mechanism of Action 35
Assessment by Route of Administration 37
Assessment by Molecule Type 39
Drug Profiles 41
ALN-CC5 – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
belimumab – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
BKT-130 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
CK-2066260 – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
eculizumab – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
GL-2045 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
HL-161 – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
immune globulin (human) – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
NT-1654 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Recombinant Protein for Myasthenia Gravis – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Recombinant Protein to Antagonize LTB4 and C5 for Respiratory, Immunological, CNS and Hematological Disorders – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Regenemab – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
tacrolimus – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
tirasemtiv – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
Vaccine for Myasthenia Gravis – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Vaccine for Myasthenia Gravis – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
Myasthenia Gravis – Recent Pipeline Updates 69
Myasthenia Gravis – Dormant Projects 85
Myasthenia Gravis – Discontinued Products 86
Myasthenia Gravis – Product Development Milestones 87
Featured News & Press Releases 87
Dec 10, 2014: Soliris (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Myasthenia Gravis 87
Sep 16, 2014: Alnylam Presents New Pre-Clinical Data with ALN-CC5, a Subcutaneously Administered RNAi Therapeutic Targeting Complement Component C5 in Development for the Treatment of Complement-Mediated Diseases 88
Aug 01, 2014: European Commission Grants Orphan Drug Designation to Soliris (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG) 89
Jun 17, 2014: FDA Grants Orphan Drug Designation to Soliris (eculizumab) for the Treatment of Patients with Myasthenia Gravis 90
Jun 09, 2014: Alnylam Presents New Pre-Clinical Data with Development Candidate for ALN-CC5, a Subcutaneously Administered RNAi Therapeutic Targeting Complement Component C5 in Development for the Treatment of Complement-Mediated Diseases 90
Apr 24, 2014: Alexion Initiates Multinational Registration Trials of Eculizumab as a Potential Treatment for Patients with Relapsing Neuromyelitis Optica and Refractory Generalized Myasthenia Gravis 92
Apr 24, 2014: Toleranzia supported by VINNOVA 93
Dec 08, 2013: New Alnylam Pre-clinical Results on ALN-CC5, an RNAi Therapeutic Targeting Complement Component C5 for the Treatment of Complement-Mediated Diseases, Demonstrate up to 98% Serum C5 Knockdown and up to 94% Inhibition of Hemolytic Activity in Non-Human Primates 93
Jun 20, 2013: Alnylam Scientists Present Preclinical Data With ALN-CC5 For Treatment Of Complement-mediated Diseases 96
Mar 21, 2013: Cytokinetics Announces Presentation Of Phase IIA Clinical Trial Data Of Tirasemtiv In Patients With Myasthenia Gravis 97
Appendix 99
Methodology 99
Coverage 99
Secondary Research 99
Primary Research 99
Expert Panel Validation 99
Contact Us 100
Disclaimer 100
【レポート販売概要】
■ タイトル：重症筋無力症(Myasthenia Gravis)の治療薬パイプライン動向（2015年上半期版）■ 英文：Myasthenia Gravis - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6062IDB
■ 調査対象地域：グローバル
- 自動料金収受（AFC）の世界市場予測（～2021）MarketsandMarkets forecast the Automated Fare Collection market size to grow from USD 6.42 Billion in 2016 to USD 11.95 Billion by 2021, at a compound annual growth rate (CAGR) of 13.2%. The AFC system can increase commuting convenience inter and intra-city. AFC has the potential to widen customer bases for transport systems and establishments, because end-users gravitate towards solutions that ma …
- BRIC（ブラジル/ロシア/インド/中国）の経皮経肝胆道造影（PTC）処置動向（～2020）BRIC Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures Outlook to 2020", provides key market data on the BRIC Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures. The report provides procedure volumes within market segm …
- 難燃剤の世界市場：三水和アルミナ（ATH）、酸化アンチモン、臭素系、塩素系、リン系Flame retardants are key components used in reducing the devastating effect of fire mishaps on people, property, and the environment. Most common elements used as flame retardants are bromine, chlorine, and phosphorous. The compounds of these elements are added to or treat potentially flammable materials. Flame retardants stop the fire by interacting with the fire cycle in the gaseous phase and st …
- ポリイソブチレン（PIB）の世界市場分析：製品別（高分子量、中分子量、低分子量）、用途別（自動車、添加剤）、セグメント予測The global polyisobutylene (PIB) market is expected to reach USD 7.71 billion by 2024, according to a new report by Grand View Research, Inc. Rising product use in pharmaceutical industry in emerging markets such as China and India are expected to drive global polyisobutylene market growth over the next eight years. The rapid growth of the automotive industry in emerging economies of Asia Pacific …
- 世界の胎児・新生児装備市場動向（2012-2016）TechNavio's analysts forecast the Global Fetal and Neonatal Care Equipment market to grow at a CAGR of 6.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for portable equipment. The Global Fetal and Neonatal Care Equipment market has also been witnessing an increase in the number of product launches. However, small and medium- …
- Oncology Therapeutics Market in India to 2018 – Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational PlayersOncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players Summary GBI Research, the leading business intelligence provider, has released its latest research, "Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Am …
- 2014年戦略提言：世界の止血診断検査市場Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100.SummaryThis comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years. The report explores bus …
- 世界の半導体産業における炭化ケイ素（SiC）市場予測及び分析：SiCパワー半導体、SiC光半導体、SiC高温半導体A semiconductor device, is expected to operate in any harsh environment an industry can offer; however, this is not possible with a silicon based semiconductor device. A Silicon based semiconductor device is capable to operates at a temperature of 300°C, whereas the industry requires semiconductor devices, which can operate at much higher temperature, voltage, and frequencies. Such enhancement in …
- 世界のCPDM（Collaborative Product Definition Management）ソリューション市場（2014-2018）About Collaborative Product Definition Management The use of cPDM software solutions is a strategic business approach that applies a consistent set of business solutions to collaboratively provide effective and efficient methods for managing the functions of PLM. These solutions facilitate effective product data management, collaborative product visualization, collaborative product commerce, effec …
- スマート抗菌性コーティング及び表面の世界市場Smart antimicrobial coatings and surfaces represent an important element of the smart materials space. The market for smart antimicrobial coatings and surfaces is driven by the need to selectively combat new threats from bacteria, viruses and fungi. Also important to the future of smart antimicrobial coatings is the mandate to reduce hospital-acquired infections. But, the opportunity for antimicro …
- 世界のトルエンジイソシアネート市場2015The Global Toluene Diisocyanate Industry Report 2015 is a professional and in-depth study on the current state of the Toluene Diisocyanate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Toluene Diisocyanate market analysis is provided for the international markets including development trends, com …
- 世界のスマートフォン市場予測2015-2019This report presents worldwide mobile phone market forecast, including a review of recent years and a forecast for the period 2015-2019, with breakdowns by system technology and region. It also examines mobile phone market volume and market share by system technology for all the world's main regions separately, including North America, Latin America, Western Europe, Eastern Europe, Middle East and …
- ブラシ付きDCモーターの世界市場展望2017-20276According to Stratistics MRC, the Global Brushed DC Motors market accounted to grow at a CAGR of 6.5% during the forecast period. Some of the key factors such as increased application of brushed DC motors in metallurgy equipment, oil and gas, power, and chemical industries are boosting the market growth. However, less maintenance due to the lack of brushes is hindering the market growth. Brush DC …
- マーケティング・リソース・マネジメント（MRM）の世界市場About MRM Marketing Resource Management (MRM) is a set of processes that enhance ( through applications such as brand management and financial management tools) an organization’s capabilities for analyzing and optimizing marketing resources (external and internal). MRM applications enable organizations: • MRM helps in planning and creating budgets with complete marketing activities and programs th …
- 静脈穿刺法処置の世界市場予測（～2021年）Venipuncture is the procedure of collecting blood from veins through venous access. Intravenous cannulation access is the method to get venous access for venipuncture. Distal to the antecubital fossa in deep-arm veins allows most successful cannulation. Moreover, medical condition of the patient and the experience and training of the technician performing the peripheral intravenous (PIV) access in …
